NCT02819466

Brief Summary

Aspiration pneumonia is a dreaded complication of anaesthesia because of its prevalence (1/3,886 cases in elective anaesthesia and 1/895 cases in emergency settings) and its high morbidity and mortality (3 to 9%). This chemical and/or infectious pneumonia is secondary to passage of the gastric contents into the unprotected upper airways during general anaesthesia. The prognosis depends on three factors: the presence of food debris, and the acidity and volume of the gastric contents. To prevent this complication, the French society of anaesthesia and intensive care recommends preoperative fasting rules and, in patients presenting risk factors for aspiration, the use of antacids and rapid sequence intubation. This preventive strategy is associated with certain adverse events: deferred operative procedures, discomfort and hypoglycaemia secondary to fasting, more frequent anaphylactic complications, and memory of anaesthetic induction. Over recent years, ultrasound has become more widely used by anaesthetists for local anaesthesia, vascular catheterization, haemodynamic monitoring and, more recently, 2D ultrasound estimation of intragastric volume. However, 2D ultrasound estimation of intragastric volume presents several limitations: because of the complex shape of the stomach, this technique requires a long learning curve and the measured volume is poorly correlated with reference techniques (MRI and 99Tc scintigraphy). Two studies have recently measured intragastric volume by three dimensional ultrasound with promising results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 28, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 30, 2016

Completed
Last Updated

June 30, 2016

Status Verified

June 1, 2016

Enrollment Period

2.2 years

First QC Date

June 28, 2016

Last Update Submit

June 28, 2016

Conditions

Keywords

intragastric volumestomachfasting

Outcome Measures

Primary Outcomes (1)

  • success rate of ultrasound visualization of the stomach while fasting

    success rate of ultrasound visualization of the stomach while fasting

    Day 0

Secondary Outcomes (4)

  • ultrasound visualization of the fasting stomach learning curve

    Day 0

  • measured difference of antral surface area

    Day 0

  • absolute error of the volume measured

    Day 0

  • relative error of the volume measured

    Day 0

Study Arms (1)

volunteers

Healthy volunteers over the age of 18 years employed by Amiens University Hospital 3D echography

Device: 3D echography

Interventions

ultrasound visualization of the stomach in fasting patients.

volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers fasting

You may qualify if:

  • Healthy volunteers over the age of 18 years employed by Amiens University Hospital and covered by French national health insurance.
  • Fasting (last meal \> 6 hours and last drink of water, tea or coffee \> 2 hours)
  • Signature of the free and informed written consent form.

You may not qualify if:

  • Pregnant woman.
  • Presence of diseases or treatments that alter (slow or accelerate) gastric emptying.
  • Presence of swallowing disorders.
  • History of gastric or supramesocolic surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80054, France

Location

MeSH Terms

Conditions

Fasting

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Edouard SECQ, PhD

    CHU Amiens

    PRINCIPAL INVESTIGATOR
  • Emmanuel LORNE, MD, PhD

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2016

First Posted

June 30, 2016

Study Start

April 1, 2013

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

June 30, 2016

Record last verified: 2016-06

Locations